TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MIRM

Mirum Pharmaceuticals Inc

Healthcare · Biotechnology

89.70$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Mirum Pharmaceuticals Inc (MIRM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,045 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MIRM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
651 647 652 661 668 671 690 726 785 843 891 1,045
389 388 389 368 387 393 411 453 531 550 569 636
303 286 303 233 223 223 212 228 282 297 325 331
306 286 303 278 284 280 278 305 376 383 386 438
48 68 55 60 69 78 96 107 107 123 133 145
22 22 22 20 22 22 22 23 24 25 26 26
2.2 – – – – – – – – – – –
258 253 257 262 256 250 244 238 232 261 254 247
382 398 417 432 436 445 457 471 493 528 648 1,055
75 87 106 112 116 127 128 145 160 206 273 223
1.1 1.1 0.4 1.1 1.5 1.7 1.6 2.1 2.0 2.1 2.4 –
7.4 7.4 16 9.8 9.5 15 12 18 12 9.6 59 23
306 306 307 307 308 308 309 309 309 310 310 750
269 249 235 229 232 226 233 255 292 315 242 -10
-521 -556 -582 -606 -620 -644 -659 -665 -662 -668 -1,458 -1,525
41 47 47 47 48 48 49 50 57 50 59 63

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?